UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A AMENDMENT TO APPLICATION OR REPORT Filed pursuant to Section 12, 13, or 15(d) of THE SECURITIES EXCHANGE ACT OF 1934 DEKALB Genetics Corporation --------------------------- (Exact name of registrant as specified in charter) AMENDMENT NO. 1 The undersigned registrant hereby amends the following items, financial statements, exhibits or other portions of its Quarterly Report for the three month period ended November 30, 1995 on form 10-Q as set forth in the pages attached hereto: Exhibit 27 - Financial Data Schedule Exhibit 27 - Restated Financial Data Schedule for the three month period ended November 30, 1994 Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this amendment to be signed on its behalf by the undersigned, thereunto duly authorized. Date: February 21, 1996 Item 6. Exhibits and Reports on Form 8-K Page - ----------------------------------------- ---- (a) Exhibit 11 - Earnings Per Share Computation 12 Exhibit 27 - Financial Data Schedule Exhibit 27 - Restated Financial Data Schedule For the three month period ended November 30, 1994 (b) Reports on Form 8-K - No Form 8-K was filed during the three months ended November 30, 1995. SIGNATURE --------- Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. DEKALB Genetics Corporation --------------------------- Date: February 21, 1996 Thomas R. Rauman --------------------------------- (Signature) Thomas R. Rauman Vice President-Finance, Chief Financial Officer